Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313336891> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W2313336891 endingPage "192" @default.
- W2313336891 startingPage "185" @default.
- W2313336891 abstract "Forty eight members belonged to Japan Self Defense Force took part in ONUMOZ (Operation des Nations Unisis en Mozambique) as the second Movement Control Company from Nov. 1993 to Jun. 1994. I belonged to the company and stayed in Mozambique during the period. As malaria is rampant in Mozambique, I used mefloquin 250mg/week as prophylaxis follwing the recommendations of ONUMOZ, W.H.O. and the Ministry of Health in France. In view of the necessary concentration of the drug and the incubation period of Plasmodium falciparum, we took the drug from the day one week before we left Japan to the day four weeks after returning. The total tablets each members took was 36 (except for four who dropped out). We investigated the symptomatic and laboratory side effects of this prophylactic treatment.The following symptoms were observed as side effects of mefloquin : general fatigue 16.7%, headache 12.5%, nausea & vomiting 4.2%, vertigo 2.1%, diarrhea 2.1% (two cases each of general fatigue and headache overlapped). Mean WBC was evevated post-return in comparison to pre-departure. Liver function of four cases deteriorated slightly in comparison to pre-departure, three months after arriving, and post-return. Two each members who suffered general fatigue and headache prolonged the period of taking the drug for one week to two weeks from 4 months after arriving to 4 weeks after returning because the symptoms had worsened. But there were no serious side effects during the prophylactic period.Over 200 members of ONUMOZ contracted malaria from Feb. 1994 to Apr. 1994, but I had no malaria outbreak in the Japanese contingent.ONUMOZ provided mefloquin to all members for prophylaxis and two out of three field hospital used mefloquin for malaria treatment as the first choice, but no malaria resistant to mefloquin had been reported as of the beginning of August 1994.We conclude that mefloquin is effective for malaria prophylaxis in Mozambique, and minor side effects are observed in only 33.3% of subjects in good health." @default.
- W2313336891 created "2016-06-24" @default.
- W2313336891 creator A5079222672 @default.
- W2313336891 date "1994-01-01" @default.
- W2313336891 modified "2023-09-25" @default.
- W2313336891 title "Side effects with mefloquin for long-term malaria prophylaxis." @default.
- W2313336891 cites W2064101749 @default.
- W2313336891 cites W2161801041 @default.
- W2313336891 doi "https://doi.org/10.2149/tmh1973.22.185" @default.
- W2313336891 hasPublicationYear "1994" @default.
- W2313336891 type Work @default.
- W2313336891 sameAs 2313336891 @default.
- W2313336891 citedByCount "5" @default.
- W2313336891 crossrefType "journal-article" @default.
- W2313336891 hasAuthorship W2313336891A5079222672 @default.
- W2313336891 hasBestOaLocation W23133368911 @default.
- W2313336891 hasConcept C126322002 @default.
- W2313336891 hasConcept C138885662 @default.
- W2313336891 hasConcept C141071460 @default.
- W2313336891 hasConcept C187212893 @default.
- W2313336891 hasConcept C203014093 @default.
- W2313336891 hasConcept C27206212 @default.
- W2313336891 hasConcept C2778048844 @default.
- W2313336891 hasConcept C2779142074 @default.
- W2313336891 hasConcept C2779802037 @default.
- W2313336891 hasConcept C2780580376 @default.
- W2313336891 hasConcept C2780852908 @default.
- W2313336891 hasConcept C521751864 @default.
- W2313336891 hasConcept C71924100 @default.
- W2313336891 hasConceptScore W2313336891C126322002 @default.
- W2313336891 hasConceptScore W2313336891C138885662 @default.
- W2313336891 hasConceptScore W2313336891C141071460 @default.
- W2313336891 hasConceptScore W2313336891C187212893 @default.
- W2313336891 hasConceptScore W2313336891C203014093 @default.
- W2313336891 hasConceptScore W2313336891C27206212 @default.
- W2313336891 hasConceptScore W2313336891C2778048844 @default.
- W2313336891 hasConceptScore W2313336891C2779142074 @default.
- W2313336891 hasConceptScore W2313336891C2779802037 @default.
- W2313336891 hasConceptScore W2313336891C2780580376 @default.
- W2313336891 hasConceptScore W2313336891C2780852908 @default.
- W2313336891 hasConceptScore W2313336891C521751864 @default.
- W2313336891 hasConceptScore W2313336891C71924100 @default.
- W2313336891 hasIssue "4" @default.
- W2313336891 hasLocation W23133368911 @default.
- W2313336891 hasOpenAccess W2313336891 @default.
- W2313336891 hasPrimaryLocation W23133368911 @default.
- W2313336891 hasRelatedWork W1896557489 @default.
- W2313336891 hasRelatedWork W1985468859 @default.
- W2313336891 hasRelatedWork W2031311309 @default.
- W2313336891 hasRelatedWork W2041128529 @default.
- W2313336891 hasRelatedWork W2468258954 @default.
- W2313336891 hasRelatedWork W2751339230 @default.
- W2313336891 hasRelatedWork W3200163803 @default.
- W2313336891 hasRelatedWork W3217631918 @default.
- W2313336891 hasRelatedWork W4255866911 @default.
- W2313336891 hasRelatedWork W3103772803 @default.
- W2313336891 hasVolume "22" @default.
- W2313336891 isParatext "false" @default.
- W2313336891 isRetracted "false" @default.
- W2313336891 magId "2313336891" @default.
- W2313336891 workType "article" @default.